Interleukin-6 and procalcitonin in children with sepsis and septic shock

Cytokine

Volumn 43, Issue 2, 2008, Pages 160-164

  Fioretto, José R ^a   Martin, Joelma G ^a   Kurokawa, Cilmery S ^a   Carpi, Mário F ^a   Bonatto, Rossano C ^a   Ricchetti, Sandra M Q ^a   de Moraes, Marcos A ^a   Padovani, Carlos R ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Children; Interleukin 6; Procalcitonin; Sepsis; Septic shock

Indexed keywords

INTERLEUKIN 6; PROCALCITONIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL INDICATOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE;

ADOLESCENT; CALCITONIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-6; MALE; PROTEIN PRECURSORS; SEPSIS; TIME FACTORS;

EID: 48049087623     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.05.005     Document Type: Article

References (45)

1. Angus D.C., and Wax R.S. Epidemiology of sepsis: an update. Crit Care Med 29 Suppl. 7 (2001) S109-S116
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
3. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 (2003) 1250-1256
4. Meisner M. Biomarkers of sepsis: clinically useful?. Curr Opin Crit Care 11 (2005) 473-480
5. Carrol E.D., Thomson A.P.J., and Hart C.A. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 20 (2002) 1-9
6. Casado-Flores J., Blacon-Quirós A., Asensio J., Arranz E., Garrote J.A., and Nieto M. Serum procalcitonin in children with suspected sepsis: a comparison with C-protein and neutrophil count. Pediatr Crit Care Med 4 (2003) 190-195
7. Fendler W.M., and Piotrowski A.J. Procalcitonin in the early diagnosis of nosocomial sepsis in preterm neonates. Paediatr Child Health 44 (2008) 114-118
8. Ugarte H., Silva E., Mercan D., De Mendonca A., and Vincent J.L. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27 (1999) 498-504
9. Lapillonne A., Basson E., Monneret G., Bienvenu J., and Salle B.L. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet 351 (1998) 1211-1212
10. Becker K.L., Snider R., and Nylen E.S. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 36 (2008) 941-952
11. Tang B.M.P., Eslick G.D., Craig J.C., and McLean A.S. Accuracy of Procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7 (2007) 210-217
12. Meisner M. Biochemistry. In: Meisner M. (Ed). Procalcitonin (PCT): A new, innovative infection parameter. Biochemical and clinical aspects (2000), Georg Thieme Verlag, Stuttgard 15-45
13. Fink M.P. The prevention and treatment of sepsis: is interleukin-6 a drug target or a drug?. Crit Care Med 34 (2006) 919-921
14. Lever A., and Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ 335 (2007) 879-883
15. Selberg O., Hartmut H., Martin M., Klos A., Bautsch W., and Kohl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 28 (2000) 2793-2798
16. Oda S., Hirasawa H., Shiga H., Nakanishi K., Matsuda K., and Nakamua M. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 29 (2005) 169-175
17. Hack C.E., De Groote E.R., Felt-Bersma R.J.F., et al. Increased plasma levels of interleukin-6 in sepsis. Blood 74 (1989) 1704-1710
18. Casey L., Balk R.A., and Bone R.C. Plasma cytokine and endotoxin levels correlate with survival in patients with septic syndrome. Ann Intern Med 119 (1993) 771-778
19. Makhija P., Yadav S., and Thakur A. Tumor necrosis factor alpha and interleukin 6 in infants with sepsis. Indian Pediatr 42 (2005) 1024-1028
20. Verboon-Maciolek M.A., Thijsen S.F., Hemels M.A., Menses M., van Loon A.M., Krediet T.G., et al. Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res 59 (2006) 457-461
21. Muller B., Becker K., Schachinger H., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28 (2000) 977-983
22. Pinsky M.R., Vincent J.L., Deviere J., et al. Serum cytokine levels in human septic shock. Relation to multiple-organ failure and mortality. Chest 103 (1993) 65-75
23. Resch B., Gusenleitner W., and Muller W.D. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatrica 92 (2003) 243-245
24. Kocabas E., Sarikçioglu A., Aksaray N., Seydaoglu G., Seyhun Y., and Yaman A. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the diagnosis of neonatal sepsis. Turk J Pediatr 49 (2007) 7-20
25. Stryjewsky G.R., Nylen E.S., Bell M.J., Snider R.H., Becker K.L., Wu A., et al. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med 6 (2005) 129-135
26. Kitanovski L., Jazbec J., Hojker S., Gubina M., and Derganc M. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur J Clin Microbiol Infect Dis 25 (2006) 413-415
27. Carcillo J.A., Fields A.I., and Task Force Committee Members. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 30 (2002) 1365-1378
28. Wilkinson J.D., Pollack M.M., Glass N.L., Kanter R.K., Katz R.W., and Steinhart C.M. Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr 111 (1987) 324-328
29. Pollack M.M., Ruttimann E.U., and Getson P.R. Pediatric risk of mortality (PRISM) score. Crit Care Med 16 (1988) 1110-1116
30. Carrol E.D., Newland P., Thomson A.P., and Hart C.A. Prognostic value of procalcitonin in children with meningococcal sepsis. Crit Care Med 33 (2005) 224-225
31. Pastor Peidró J.A., González de Dios J., Uran Moreno M.M., Garcia Aviles B., de la Morena Campilo A., and Moya Benavent M. Usefulness of procalcitonin as an early diagnositic testo f neonatal sepsis in newborns with risk factors for infection. An Pediatr (Barc) 67 (2007) 530-535
32. Muller B., and Becker K.L. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 131 (2001) 595-602
33. Luzzani A., Polati E., Dorizzi R., Rungatscher A., Pavan R., and Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 31 (2003) 1737-1741
34. Assicot M., Gendrel D., Carsin H., Raymond J., Guilband J., and Bohuon C. High serum procalcitonin in patients with sepsis and infection. Lancet 341 (1993) 515-518
35. Sikora J.P., Chlebna-Sokol D., and Krzyzanska-Oberbek A. Proinflammatory cytokines (IL-6, IL-8), cytokine inhibitors (IL-6sR, sTNFRII) and anti-inflammatory cytokines (IL-10, IL-13) in the pathogenesis of sepsis in newborn and infants. Arch Immunol Ther Exp 49 (2001) 399-404
36. Brunkhorst F.M., Heinz U., and Forycki Z.F. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 24 (1998) 888-889
37. Kushimoto S., Shibata Y., Koido Y., Kawai M., Yokota H., and Yamamoto Y. The clinical usefulness of procalcitonin measurement for assessing the severity of bacterial infection in critically ill patients requiring corticosteroid therapy. J Nippon Med Sch 74 (2007) 236-240
38. Kruif M.D., Lemaire L.C., Giebelen I.A., Struck J., Morgenthaler N.G., Papassotiriou J., et al. The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med 34 (2008) 518-522
39. Harbarth S., Holeckova K., Froidevaux C., Pittet D., Ricou B., Grau G.E., et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected of sepsis. Am J Respir Crit Care Med 164 (2001) 396-402
40. Pathan N., Williams E.J., Oragui E.E., Stephens A.C., and Levin M. Changes in the interleukin-6/soluble interleukin-6 receptor axis in meningococcal septic shock. Crit Care Med 33 (2005) 1839-1844
41. Muller B., Becker K.L., Schachinger H., Rickenbacher P.R., Huber P.R., Zimmerli W., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28 (2000) 977-983
42. Rodriguez-Gaspar M., Santolaria F., Jarque-Lopez A., Gonzalez-Reimers E., Milena A., de la Vega M.J., et al. Prognostic value of cytokines in SIRS general medical patients. Cytokine 15 (2001) 232-236
43. Gogos C.A., Skoutelis A., Lekkou E., et al. Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother 48 (2004) 2793-2798
44. Oppert M., Schindler R., Husung C., Offermann K., Graf K.J., Boenisch O., et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 33 (2005) 2457-2464
45. Quante T., Ng Y.C., Ramsay E.E., Henness S., Allen J.C., Parmentier J., et al. Corticosteroids reduce IL-6 in ASM cells via upregulation of MKP-1. Am J Respir Cell Mol Biol (2008) 28